41.4 F
New York
Sunday, February 28, 2021

Gilead Sciences [NASDAQ: GILD] Announces Agreement With Jounce [NASDAQ: JNCE]

Must read

ChargePoint Inc [NYSE: CHPT] Announces The Completion Of Business Combination With SwithBack Energy

ChargePoint Inc revealed that the company has completed its business merger with Switchback Energy Acquisition Corp. Additionally, The companies uncover the close of...

Bank of America [NYSE: BAC] Announced Paid Break For Employees For Covid Vaccination

Bank Of America Corp  announced that the company will give its staff paid time off for covid vaccination. Moreover, the company states that...

Fidelity D and D Bancorp [NASDAQ: FDBC] Executes Acquisition Of Landmark Bancorp

Fidelity D and D Bancorp, Inc. announced the acquisition of Landmark Bancorp, Inc. The company reported executing the contract in which Landmark will...

Atlassian Corp [NYSE: TEAM] Announces The Acquisition Of Chartio

Atlassian Corporation announced the acquisition of Chartio. The acquisition of Chartio to the Atlassian stage will give a robust analytic experience across our...

Gilead Sciences, Inc. [NASDAQ: GILD] announced Tuesday it has signed a new deal with Jounce Therapeutics, Inc. [NASDAQ: JNCE] for a novel Immunotherapy program. The purpose of the deal is to license the JTX-1811 program.

Gilead Sciences will have exclusive rights to develop and commercialize Anti-CCR8 antibodies. JTX-1811 is a monoclonal antibody developed to selectively destroy immunosuppressive tumor-infiltrating T regulatory (TITR) cells.

Shares of Gilead Sciences traded down 1.00% after losing -0.67 on Tuesday. It has a day low range of 66.06 and a day high range of 66.47.

Gilead Sciences Inc last closed at $66.08, in a 52-week range of $60.89 to $85.97. It has traded up 8.52% from its 52-weeks low and traded down -23.14% from its 52-weeks high.

Let’s take a quick look at its profitability, it has a return on assets (ROA) of -0.40%, return on equity (ROE) of -1.20%, and return on investment (ROI) of 9.50%.

Furthermore, Gilead Sciences has a Gross Margin of 78.60%, a Profit Margin of -1.20%, and an Operating Margin of -4.30%.

Gilead Sciences (GILD) has a current ratio of 2.30. Moreover, its quick ratio is 2.20. The market cap of GILD has remained high, hitting $84.06 billion at the time of writing.

Now looking at the share price of Jounce Therapeutics soared 70.04%, as it gained +3.39 on Tuesday. It has a day low and high range of $7.10 and $8.50, respectively.

The share price of Jounce Therapeutics went from a low point around $2.79 to briefly over $10.00 in the past 52 weeks, though shares have since pulled back to $8.23. JNCE market cap has remained high, hitting $157.59 million at the time of writing.

Turing our focus on its profitability, its return on assets (ROA), return on equity (ROE), and return on investment (ROI) is 11.30%, 13.50%, and 30.20%. Furthermore, its Profit Margin is 18.20%.

If we look at the terms of the Agreement, will pays an upfront payment of $85 million to, and a $35 million equity investment at a premium in, Jounce upon closing.

Additionally, Jounce may get up to an additional $685 million in future clinical, regulatory, and commercial milestone payments.

Jounce will lead the development of JTX-1811 through IND clearance, after that Gilead Sciences will have exclusive rights to develop JTX-1811. The deal is expected to close in the second half of 2020.

More articles

Latest article

MongoDB [NASDAQ: MDB] Announces Extended 5-year Collaboration With Google Cloud

MongoDB Inc. , reported an extended five-year collaboration that will stretch out their current go-to-market relationship. Moreover, it will provide a more profound integration...

Humana Inc [NYSE: HUM] Announces Collaboration With Mercy

Mercy and  Humana Inc. announces that the companies have collaborated. Both the companies inked a contract to extend patient access to virtual healthcare...

International Paper [NYSE: IP] Reports Purchase Of Berkley MF LLC

International Paper has purchased Berkley International's Molded Fiber (Pulp) production subsidiary, Berkley MF LLC. Berkley is the provider of essential packaging and e-commerce...

Perspecta [NYSE: PRSP] Received an Award For $38 Million To Continue Supporting DMDC

Perspecta Inc. , reported that the company has been granted an award to keep supporting the Defense Manpower Data Center (DMDC) with a strategic...

SG Blocks [NASDAQ: SGBX] Continues Growth Through The Execution Of 19-acre Acquisition Contract

SG Blocks, Inc. executes the contract to purchase the 19 acre Echo sites and all of its multiple structures. The company reported the...

HP Inc [NYSE: HPQ] Enters Into A Contract To Purchase HyperX

HP Inc. revealed that the company entered into a contract to purchase HyperX. It is the gaming subsidiary of Kingston Technology Company. Moreover,...

AT&T [NYSE: T] Might Sell Its Large Minority Stake At Direct TV/ U-Verse Operation To TPG

AT&T is approaching a deal to sell a significant minority stake in its DirecTV, AT&T TV Now, and U-Verse business to TPG. Additionally,...

Wipro [NYSE: WIT] Entered Into A Collaborative Agreement With Uptake

Uptake revealed that the company has collaborated with Wipro limited . The companies inked the agreement to deliver industrial intelligence for the utilities, chemical...